GlassScriptPhysician profile
Lili Barsky
NPI 1184038671
$3,580.16
in general payments reported to CMS, 2019-2025
11 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $349 · 2023: $1,567 · 2024: $1,424 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,975 · Education: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,975.23 |
| Education | $256.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,244.07 | 2023-2024 | Cardiomems, Ensite, Assurity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $721.91 | 2022-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $473.89 | 2023 | Opsumit, Uptravi |
| Itamar Medical INC | $259.45 | 2023 | Watchpatone |
| Medtronic, INC. | $236.37 | 2023 | Corevalve Evolut R |
| Shockwave Medical, INC | $149.98 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $122.17 | 2023 | Optimizer |
| Sanofi-Aventis U.S. LLC | $120.81 | 2023 | |
| Lantheus Medical Imaging, INC. | $115.74 | 2022 | |
| Abiomed | $107.78 | 2025 | |
| United Therapeutics Corporation | $27.99 | 2023 | Tyvaso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lili Barsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.